---
title: Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its
  Open-Label Extension
date: '2023-12-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38055186/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231206170903&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Initial treprostinil assignment improved survival in the
  entire data set; those who began treprostinil after a clinical worsening in the
  placebo arm and tolerated drug to week 48 enjoyed substantial functional ...'
disable_comments: true
---
CONCLUSION: Initial treprostinil assignment improved survival in the entire data set; those who began treprostinil after a clinical worsening in the placebo arm and tolerated drug to week 48 enjoyed substantial functional ...